Understanding T Cells in Vitiligo
Autoreactive T Cell Function in Vitiligo
This research explores how certain immune cells, called T cells, cause the skin condition vitiligo, which leads to white spots on the skin.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11159470 on NIH RePORTER |
What this research studies
Vitiligo is an autoimmune skin condition where specific immune cells, known as cytotoxic CD8+ T cells, mistakenly attack and destroy pigment-making cells in the skin. This project aims to understand the detailed ways these T cells behave, including how they find their targets and activate other immune cells. By studying vitiligo, which is easier to observe and sample in human patients, we hope to gain a comprehensive understanding of how organ-specific autoimmune diseases develop. This knowledge could also shed light on other autoimmune conditions like type 1 diabetes and multiple sclerosis.
Who could benefit from this research
Good fit: This foundational research is relevant for individuals living with vitiligo or other autoimmune conditions, as it seeks to uncover the basic mechanisms of these diseases.
Not a fit: Patients not affected by vitiligo or other autoimmune diseases would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of vitiligo and other autoimmune diseases, potentially paving the way for new and more effective treatments.
How similar studies have performed: While previous work has characterized autoreactive T cell responses, this project aims to provide a more comprehensive and nuanced understanding of their behavior within human tissue.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Kent, Sally Choate — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Kent, Sally Choate
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.